UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000022254
Receipt number R000025612
Scientific Title Phase II Clinical Trial of Dasatinib Therapy Aiming for Treatment-Free Remission in Patients with Chronic Phase Chronic Myeloid Leukemia
Date of disclosure of the study information 2016/05/21
Last modified on 2023/11/26 14:21:51

No. Disposal Last modified on Item of update
1 Insert 2016/05/09 21:48:31
2 Update 2016/05/23 18:48:37 Acronym
Acronym
3 Update 2016/06/20 11:33:46 Recruitment status
4 Update 2018/05/15 18:28:39 Recruitment status
5 Update 2018/11/15 18:28:08 Email
Email
Email1
6 Update 2019/05/16 18:41:27 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
TEL

Last name of contact person

Last name of contact person
Zip code
Address
TEL
Organization
Organization
Address
Address
Tel
Email
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
7 Update 2019/05/16 18:43:38 Address
8 Update 2019/05/16 18:50:53 Date of IRB
Last follow-up date
9 Update 2019/05/20 12:45:17 Address
Address
10 Update 2019/11/14 17:14:28 Recruitment status
11 Update 2019/11/14 17:15:10 Number of participants that the trial has enrolled
12 Update 2020/05/22 10:24:11 Last follow-up date
Date analysis concluded
13 Update 2023/11/26 14:19:07 Recruitment status
14 Update 2023/11/26 14:21:51 URL releasing protocol
Publication of results
URL related to results and publications
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures